| Filed On | Filing |
|---|---|
| 14 Feb 2018 |
Form 5: Walker Luke Nathaniel, SVP, Clinical Development
Holds 9,002 shares of Common Stock |
| 10 Feb 2017 |
Form 5: Spiegelman Daniel K, Director
Received 2,723 shares by exercise or conversion · Gave up 681 shares to cover exercise price or tax ($5.03K) |
| 10 Feb 2017 |
Form 5: Love Ted W, Director
Received 2,723 shares by exercise or conversion · Gave up 681 shares to cover exercise price or tax ($5.03K) |
| 10 Feb 2017 |
Form 5: Jackson Richard L., Director
Received 2,723 shares by exercise or conversion · Gave up 681 shares to cover exercise price or tax ($5.03K) |
| 10 Feb 2017 |
Form 5: Henney Christopher S, Director
Received 2,723 shares by exercise or conversion · Gave up 681 shares to cover exercise price or tax ($5.03K) |
| 12 Feb 2013 |
Form 5: Eastland Julia Marie, CFO & VP Corp. Dev.
Holds 15,431 shares of Common Stock |
| 12 Feb 2013 |
Form 5: Christianson Gary, Chief Operating Officer
Holds 8,271 shares of Common Stock |
Loading...
